Darwin Global Management, Ltd. Quant / Systematic

CIK: 0001839209 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value ($000): $619,934 (100.0% shares, 0.0% debt)

Holdings (12)

NTLA INTELLIA THERAPEUTICS INC 48.6%

Value ($000) $301,141 Shares 1,859,926 Est. Cost $77.87 Unrealized 0.0%

— ACCELERON PHARMA INC 35.6%

Value ($000) $220,906 Shares 1,760,346 Est. Cost $130.05 Unrealized —

FATE FATE THERAPEUTICS INC 4.7%

Value ($000) $29,154 Shares 335,918 Est. Cost $72.37 Unrealized +11.4%

BBIO BRIDGEBIO PHARMA INC 3.3%

Value ($000) $20,532 Shares 336,817 Est. Cost $59.97 Unrealized -4.8%

BEAM BEAM THERAPEUTICS INC 2.6%

Value ($000) $16,344 Shares 126,985 Est. Cost $79.68 Unrealized 0.0%

— VERVE THERAPEUTICS INC 1.0%

Value ($000) $6,207 Shares 103,013 Est. Cost $60.25 Unrealized —

— INHIBRX INC 1.0%

Value ($000) $6,205 Shares 225,480 Est. Cost $27.97 Unrealized —

— ESSA PHARMA INC 1.0%

Value ($000) $5,958 Shares 208,524 Est. Cost $28.57 Unrealized —

KROS KEROS THERAPEUTICS INC 0.7%

Value ($000) $4,425 Shares 104,186 Est. Cost $61.83 Unrealized -12.4%

ACRS ACLARIS THERAPEUTICS INC 0.7%

Value ($000) $4,390 Shares 250,000 Est. Cost $22.72 Unrealized 0.0%

RLAY RELAY THERAPEUTICS INC 0.7%

Value ($000) $4,383 Shares 119,775 Est. Cost $43.40 Unrealized -24.1%

— GENERATION BIO CO 0.0%

Value ($000) $289 Shares 10,738 Est. Cost $28.36 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
NTLA	INTELLIA THERAPEUTICS INC	1,859,926	$301,141	48.6%	$77.87	0.0%	COM	45826J105
—	ACCELERON PHARMA INC	1,760,346	$220,906	35.6%	$130.05	—	COM	00434H108
FATE	FATE THERAPEUTICS INC	335,918	$29,154	4.7%	$72.37	+11.4%	COM	31189P102
BBIO	BRIDGEBIO PHARMA INC	336,817	$20,532	3.3%	$59.97	-4.8%	COM	10806X102
BEAM	BEAM THERAPEUTICS INC	126,985	$16,344	2.6%	$79.68	0.0%	COM	07373V105
—	VERVE THERAPEUTICS INC	103,013	$6,207	1.0%	$60.25	—	COM	92539P101
—	INHIBRX INC	225,480	$6,205	1.0%	$27.97	—	COM	45720L107
—	ESSA PHARMA INC	208,524	$5,958	1.0%	$28.57	—	COM NEW	29668H708
KROS	KEROS THERAPEUTICS INC	104,186	$4,425	0.7%	$61.83	-12.4%	COM	492327101
ACRS	ACLARIS THERAPEUTICS INC	250,000	$4,390	0.7%	$22.72	0.0%	COM	00461U105
RLAY	RELAY THERAPEUTICS INC	119,775	$4,383	0.7%	$43.40	-24.1%	COM	75943R102
—	GENERATION BIO CO	10,738	$289	0.0%	$28.36	—	COM	37148K100